Fundraising Fox
Advaxis
Monmouth Junction, US · Delaware corporation · 1 known investors
Find your way into Advaxis
Sign up to see every warm intro you have to Advaxis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Advaxis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
IG
Igor GitelmanExecutiveIgor Gitelman has held financial leadership roles including Interim Chief Financial Officer at Ayala Pharmaceuticals and Chief Financial Officer at Accu Reference Medical Lab. He holds a CPA license, an MBA degree, and SAP Certified Application Associate credential, with over 20 years of experience in accounting, finance, and audit.
AG
Andres GutierrezExecutive
KB
Kenneth BerlinExecutive
JR
John RothmanExecutive
MJ
Mark J. RosenblumExecutive
RA
Roni AppelNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$17.3M disclosed across 4 rounds · 2012–2023
▶$433.8KraisedNov 2023 · 3 investors · BiotechnologyRule 506(b)
▶$433.8KraisedNov 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andres GutierrezExecutive Officer
- Igor GitelmanExecutive Officer
- Pini OrbachDirector
- Murray GoldbergDirector
- Vered Bisker-LeibDirector
- Yuval CabillyDirector
- Bridget MartellDirector
- Roy GolanExecutive Officer
- Robert SpiegelDirector
- David SidranskyDirector
- Roni AppelDirector
- Ken A. BerlinDirector, Executive Officer
- Offering amount
- $433.8K
- Amount sold
- $433.8K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.8MraisedFeb 2022 · 6 investors · BiotechnologyRule 506(b)
▶$4.8MraisedFeb 2022 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kenneth BerlinExecutive Officer, Director
- Samir KhleifDirector
- Igor GitelmanExecutive Officer
- Roni AppelDirector
- James PattonDirector
- Andres GutierrezExecutive Officer
- David SidranskyDirector
- Richard BermanDirector
- Offering amount
- $4.8M
- Amount sold
- $4.8M
- Minimum investment
- $380K
- Finders' fees
- $295K
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.1MraisedApr 2021 · 2 investors · BiotechnologyRule 506(b)
▶$11.1MraisedApr 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Samir KhleifDirector
- Richard BermanDirector
- Igor GitelmanDirector
- Andres GutierrezExecutive Officer
- Roni AppelDirector
- Kenneth BerlinExecutive Officer, Director
- David SidranskyDirector
- James PattonDirector
- Offering amount
- $11.1M
- Amount sold
- $11.1M
- Minimum investment
- $3M
- Finders' fees
- $1.1M
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedFeb 2012 · 12 investors · BiotechnologyRule 506(b)
▶$1MraisedFeb 2012 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas MooreExecutive Officer, Director
- Richard BermanDirector
- John RothmanExecutive Officer
- Thomas McKearnDirector
- Roni A. AppelDirector
- James PattonDirector
- Mark J. RosenblumExecutive Officer
- Amount sold
- $1M
- Sales commissions
- $73.3K
- Placement agents
- Rodman & Renshaw, LLC
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Advaxis's investors?
- Advaxis's investors include Israel Biotech Fund.
- How much funding has Advaxis raised?
- Advaxis has disclosed $17.3M raised across 4 rounds.
- Where is Advaxis headquartered?
- Advaxis is headquartered in Monmouth Junction, US.